Erlotinib and platelet count decreased 
Erlotinib and platelet count decreased Patient Reports February 11, 2012
Erlotinib Side Effects Report #6125376-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 02, 2009. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, dehydration, hypophagia, hypotension, platelet count decreased. Erlotinib dosage: 100 MG QD, ORAL. Patient recovered.
Erlotinib Side Effects Report #5113448-7
Erlotinib side effect was reported by a Physician from GERMANY on Sept 05, 2006. Female patient, 68 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5145304-2
Erlotinib side effect was reported by a Physician from GERMANY on Oct 17, 2006. Female patient, 68 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, pneumonia
, white blood cell count decreased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, ENOXAPARIN, MACROGOL, METOPROLOL TARTRATE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6060251-X
Erlotinib side effect was reported by a Physician from HONG KONG on Jan 16, 2009. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cardiac arrest
, fall , platelet count decreased, viral infection , white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, FAMOTIDINE, DIHYDROCODEINE COMPOUND, ZOPICLONE, FERROUS SULPHATE, CLINDAMYCIN HYDROCHLORIDE, HYDROCORTISONE ACETATE, ISOPHANE INSULIN. Patient was hospitalized. Patient died on 01/14/2009.Erlotinib Side Effects Report #6121303-9
Erlotinib side effect was reported by a Physician from HONG KONG on Feb 27, 2009. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cardiac arrest
, fall , mouth haemorrhage, platelet count decreased, viral infection , white blood cell count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, FAMOTIDINE, DIHYDROCODEINE COMPOUND, ZOPICLONE, FERROUS SULPHATE, CLINDAMYCIN HYDROCHLORIDE, HYDROCORTISONE ACETATE. Patient was hospitalized. Patient died on 01/14/2009.Erlotinib Side Effects Report #5862116-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Aug 11, 2008. Female patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, platelet count decreased, somnolence, unresponsive to stimuli, vomiting. Erlotinib dosage: (100 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE. Patient was hospitalized. Patient died on 07/15/2008.
Erlotinib Side Effects Report #6132638-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, 60 years of age, weighting 125.2 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: culture urine positive, dehydration, escherichia infection, mucosal inflammation, platelet count decreased, pneumonia klebsiella, vomiting. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, XELODA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5829432-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 15, 2008. Female patient, 55 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, haemoglobin decreased, hyponatraemia, nausea , platelet count decreased, pyrexia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, AMLODIPINE, DOXAZOSIN, LISINOPRIL, METOPROLOL TARTRATE, OXYCONTIN, PROTONIX. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6075362-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 26, 2009. Male patient, 76 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, platelet count decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, INSULIN, EXELON, ASPIRIN, GLUCOTROL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5916942-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Male patient, 62 years of age, weighting 149.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypovolaemia, oesophagitis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5721536-7
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient died on 03/23/2008.
Erlotinib Side Effects Report #5113449-9
Erlotinib side effect was reported by a Physician from HONG KONG on Sept 01, 2006. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, gastroenteritis
, platelet count decreased. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5633822-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 08, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hyperkalaemia, hypernatraemia, interstitial lung disease, lower respiratory tract infection bacterial, no therapeutic response, platelet count decreased, pulmonary tuberculosis, respiratory failure. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with RIZE, CLONAZEPAM, METHYLCOBAL, LOXONIN, PRIMPERAN, AMITRIPTYLINE, PURSENNID, DUROTEP. Patient died.
Erlotinib Side Effects Report #5798556-X
Erlotinib side effect was reported by a Physician from JAPAN on June 13, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, depressed level of consciousness, hyperkalaemia, hypernatraemia, interstitial lung disease, platelet count decreased, pleural effusion, pneumocystis jiroveci pneumonia, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RIZE, CLONAZEPAM, METHYCOBAL, LOXONIN, PRIMPERAN, AMITRIPTYLINE, PURSENNID, FENTANYL TRANSDERMAL SYSTEM. Patient died.
Erlotinib Side Effects Report #6120264-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Female patient, 39 years of age, weighting 171.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BACTRIM DS, CLINDAMYCIN PHOSPHATE, ALBUTEROL, TYLENOL PM, PREDNISONE, DOCETAXEL, GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5320159-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, myalgia, nuclear magnetic resonance imaging abnormal, platelet count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5383679-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 63 years of age, weighting 106.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, large intestine perforation, neutropenia, peridiverticular abscess, platelet count decreased, pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, DURAGESIC, OXYCODONE, AMBIEN CR, DECADRON, COMPAZINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5174252-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 20, 2006. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, fatigue, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, TYLENOL, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5450729-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, ACETAMINOPHEN, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5822391-7
Erlotinib side effect was reported by a Physician from JAPAN on July 07, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood urea increased, cataract
, hepatic function abnormal, herpes zoster, hypoxia, paronychia, platelet count decreased, rash . Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with DECADRON, POLYFUL, EURODIN, FAMOTIDINE, DOMPERIDONE, GASMOTIN, MAGNESIUM OXIDE. Patient recovered.Erlotinib Side Effects Report #5839451-7
Erlotinib side effect was reported by a Physician from JAPAN on July 24, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #5891593-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 05, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #6121204-6
Erlotinib side effect was reported by a Physician from JAPAN on Feb 27, 2009. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #5740036-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 28, 2008. Male patient, 55 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: platelet count decreased. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with JUZENTAIHOTO, ALLOPURINOL. Patient recovered.
Erlotinib Side Effects Report #6128094-6
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2009. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ingrowing nail, platelet count decreased, rash
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEPAKENE, GLYCEOL, BETAMETHASONE, PURSENNID, MUCOSTA. Patient recovered.Erlotinib Side Effects Report #5782718-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 04, 2008. Female patient, weighting 280.0 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dehydration, granulocytes abnormal, neutrophil count decreased, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4933916-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 54 years of age, weighting 148.6 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colostomy, diverticular perforation, enterococcal infection, febrile neutropenia, haematocrit decreased, haemoglobin decreased, mental status changes, platelet count decreased, pseudomonas infection. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, ESOMEPRAZOLE, LEXAPRO, KYTRIL, LEVAQUIN, ZYPREXA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5529685-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with colon cancer metastatic, breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation
, dehydration, haemoglobin decreased, lethargy, nausea , platelet count decreased, pneumonia . Erlotinib dosage: 75 MG, QD, ORAL. During the same period patient was treated with VINFLUNINE, FENTANYL PATCH, OXYCODONE, KYTRIL, PROMETHAZINE, LEVSIN, MORPHINE, DIAZEPAM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5351034-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 23, 2007. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, gallbladder disorder, nausea
, neutropenia, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5351040-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 56 years of age, weighting 150.4 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gallbladder disorder, nausea
, neutropenia, platelet count decreased, tremor. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5736877-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, lymphadenopathy, platelet count decreased, pulmonary embolism
. Erlotinib dosage: (100 MG, QD), ORAL. Patient recovered.Erlotinib Side Effects Report #5766203-9
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, platelet count decreased, pulmonary embolism
. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with LIPITOR, ZOFRAN, COMPAZINE, CLINDAMYCIN, DECADRON, LASIX, NASONEX, OXYCONTIN. Patient recovered.Erlotinib Side Effects Report #6108684-7
Erlotinib side effect was reported by a Physician from JAPAN on Feb 20, 2009. Female patient, 77 years of age, weighting 115.7 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, rash
. Erlotinib dosage: (150 MG, QD), ORAL : (50 MG, QD), ORAL. During the same period patient was treated with NEORAL, NEUQUINON, BACTRIM, LASIX. Patient recovered.Erlotinib Side Effects Report #6051308-8
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Female patient, 71 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ADONA, TRANSAMIN, LOXONIN, MUCOSTA, FAMOTIDINE, PREDNISOLONE, HOKUNALIN, DUROTEP. Patient was hospitalized. Patient died on 05/13/2008.
Erlotinib Side Effects Report #6140673-9
Erlotinib side effect was reported by a Health Professional from JAPAN on Mar 17, 2009. Female patient, 71 years of age, weighting 96.56 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ADONA, TRANSAMIN, LOXONIN, MUCOSTA, FAMOTIDINE, PREDNISOLONE, HOKUNALIN, DUROTEP. Patient died on 05/13/2008.
Erlotinib Side Effects Report #5805265-7
Erlotinib side effect was reported by a Physician from UNITED STATES on June 20, 2008. Male patient, 68 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: platelet count decreased, red blood cell count decreased. Erlotinib dosage: (50 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, DEXAMETHASONE. Patient died.
Erlotinib Side Effects Report #6081651-8
Erlotinib side effect was reported by a Health Professional from JAPAN on Jan 30, 2009. Female patient, 53 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ingrowing nail, platelet count decreased, rash
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DEPAKENE, GLYCEOL, BETAMETHASONE, PURSENNID, MUCOSTA. Patient recovered.